- Report
- February 2024
- 250 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- September 2022
- 141 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 200 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- June 2023
- 118 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2022
- 118 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2022
- 72 Pages
Iran
From €3185EUR$3,350USD£2,675GBP
- Report
- October 2022
- 80 Pages
Europe
From €3565EUR$3,750USD£2,995GBP
- Report
- October 2022
- 82 Pages
Asia Pacific
From €3565EUR$3,750USD£2,995GBP
- Report
- October 2022
- 73 Pages
Argentina
From €3185EUR$3,350USD£2,675GBP
- Report
- September 2022
- 77 Pages
Canada
From €3185EUR$3,350USD£2,675GBP
- Report
- September 2022
- 82 Pages
Turkey
From €3185EUR$3,350USD£2,675GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- January 2023
- 30 Pages
Japan
From €2614EUR$2,750USD£2,196GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP

The Arthritis Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Arthritis drugs are used to treat the inflammation and pain associated with arthritis, a condition that affects the joints and surrounding tissues. These drugs can be divided into two main categories: non-steroidal anti-inflammatory drugs (NSAIDs) and disease-modifying antirheumatic drugs (DMARDs). NSAIDs are used to reduce inflammation and pain, while DMARDs are used to slow the progression of the disease.
The Arthritis Drug market is highly competitive, with a number of large pharmaceutical companies offering a variety of treatments. Some of the major players in the market include Pfizer, Merck, AbbVie, Johnson & Johnson, and Novartis. Show Less Read more